Sonora Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$37K Hold
100
﹤0.01% 486
2021
Q2
$38K Hold
100
0.01% 448
2021
Q1
$36K Hold
100
﹤0.01% 706
2020
Q4
$32K Sell
100
-15
-13% -$4.6K ﹤0.01% 733
2020
Q3
$31K Buy
115
+11
+11% +$2.96K ﹤0.01% 713
2020
Q2
$27K Buy
104
+4
+4% +$1.07K ﹤0.01% 660
2020
Q1
$23K Hold
100
﹤0.01% 712
2019
Q4
$30K Buy
+100
New +$27.5K ﹤0.01% 681
2019
Q3
Sell
-138
Closed -$39K 1745
2019
Q2
$39K Buy
138
+38
+38% +$10.4K ﹤0.01% 619
2019
Q1
$29K Hold
100
﹤0.01% 643
2018
Q4
$26K Hold
100
﹤0.01% 536
2018
Q3
$27K Buy
+100
New +$26K ﹤0.01% 533
2015
Q4
Sell
-101
Closed -$14K 894
2015
Q3
$14K Buy
+101
New +$15.2K ﹤0.01% 391

Other funds holding ELV

Sonora Investment Management's ELV Position: Q3 2021 in Review

Sonora Investment Management held its Elevance Health (ELV) position steady in Q3 2021 at 100 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #486.

Sonora Investment Management first reported a position in ELV in Q3 2015 and has held it in 13 quarters since. The position peaked at $39K in Q2 2019. 1,216 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

  • Sonora Investment Management held 100 shares of Elevance Health worth $37K as of Q3 2021.
  • Sonora Investment Management left its Elevance Health share count unchanged in Q3 2021.
  • Elevance Health made up ﹤0.01% of Sonora Investment Management's portfolio in Q3 2021, its #486 holding.
  • Sonora Investment Management first reported a position in Elevance Health in Q3 2015 and has held it in 13 quarters since.
  • Sonora Investment Management's Elevance Health position peaked at $39K in Q2 2019.
  • 1,216 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.